The interest rate on borrowings. [Refer: Borrowings]

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 7
-IssueDate 2025-01-01
-Paragraph 7
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard
-URIDate 2025-03-27

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

No definition available.

The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Note Expiry date 2027-01-01
-Name IAS
-Number 1
-IssueDate 2025-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard
-URIDate 2025-03-27

The cash inflow from borrowings obtained. [Refer: Borrowings]

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2025-01-01
-Paragraph 17
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_c&doctype=Standard
-URIDate 2025-03-27

Aggregate amount to be received by the company, either in exchange for new shares or warrants of the Company.

No definition available.

The payment-in-kind interest rate on borrowings.

No definition available.

Percentage premium applied to the applicable reference price to determine the conversion price of the convertible bonds.

No definition available.

Price per ordinary share at which the entity's equity securities are offered and sold in an equity offering.

No definition available.

Exercise price per share or per unit of warrants or rights outstanding.

No definition available.

Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.

No definition available.

The price per share of the conversion feature embedded in the debt instrument.

No definition available.

Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.

No definition available.

Amount of maximum additional uncommitted financing available.

No definition available.

Maximum ratio of the entity's debt to its market capitalization permitted under the debt financing agreement.

No definition available.

Amount of maximum uncommitted financing available for potential drawdown by the entity.

No definition available.

Minimum amount of equity financing required to be completed as a condition to the closing of the financing transaction.

No definition available.

Minimum amount of equity fundraising to achieve satisfy the drawdown conditions.

No definition available.

Minimum exercise amount of warrants to satisfy drawdown conditions.

No definition available.

The minimum amount to be maintained in specified secured accounts, financial covenant.

No definition available.

Number of monthly instalments

No definition available.

Number of trading days used in the calculation of the volume-weighted average price of the entity's ordinary shares.

No definition available.

Number of warrants issued

No definition available.

The nominal value per bond.

No definition available.

Threshold number of prior business days within which the company must obtain FDA approval.

No definition available.

Volume-weighted average trading price per ordinary share of the entity over the applicable 30-day period.

No definition available.

Percentage of premium applied in determining the exercise price of warrants over the applicable reference share price.

No definition available.